Brokerages expect Integer Holdings Co. (NYSE:ITGR) to post earnings per share of $0.77 for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Integer’s earnings. The highest EPS estimate is $0.81 and the lowest is $0.69. Integer posted earnings per share of $0.87 during the same quarter last year, which suggests a negative year-over-year growth rate of 11.5%. The company is expected to announce its next earnings results on Monday, February 26th.
According to Zacks, analysts expect that Integer will report full-year earnings of $2.62 per share for the current fiscal year, with EPS estimates ranging from $2.55 to $2.65. For the next year, analysts anticipate that the firm will post earnings of $3.18 per share, with EPS estimates ranging from $2.87 to $3.45. Zacks’ EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for Integer.
Integer (NYSE:ITGR) last released its earnings results on Thursday, October 26th. The medical equipment provider reported $0.82 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.04. Integer had a net margin of 1.42% and a return on equity of 11.22%. The company had revenue of $363.31 million for the quarter, compared to analysts’ expectations of $354.83 million. During the same quarter in the previous year, the company earned $0.83 EPS. Integer’s revenue for the quarter was up 4.8% on a year-over-year basis.
Integer (ITGR) traded up $0.70 on Friday, hitting $49.75. 78,500 shares of the company were exchanged, compared to its average volume of 135,250. The company has a debt-to-equity ratio of 1.95, a quick ratio of 1.37 and a current ratio of 2.58. Integer has a 52 week low of $29.90 and a 52 week high of $55.20. The stock has a market cap of $1,553.41, a PE ratio of 78.97, a price-to-earnings-growth ratio of 1.03 and a beta of 1.08.
In related news, COO Jeremy Friedman sold 8,163 shares of the company’s stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $44.89, for a total transaction of $366,437.07. Following the transaction, the chief operating officer now directly owns 17,673 shares in the company, valued at approximately $793,340.97. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Thomas J. Mazza sold 23,123 shares of the company’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $46.16, for a total transaction of $1,067,357.68. Following the transaction, the vice president now owns 26,123 shares in the company, valued at $1,205,837.68. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 100,625 shares of company stock worth $4,694,219. Insiders own 4.80% of the company’s stock.
Large investors have recently modified their holdings of the stock. UBS Asset Management Americas Inc. grew its stake in Integer by 0.5% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 18,967 shares of the medical equipment provider’s stock worth $820,000 after acquiring an additional 98 shares in the last quarter. TIAA CREF Investment Management LLC grew its stake in Integer by 0.6% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 123,410 shares of the medical equipment provider’s stock worth $5,337,000 after acquiring an additional 740 shares in the last quarter. Strs Ohio grew its stake in Integer by 5.3% in the 4th quarter. Strs Ohio now owns 21,900 shares of the medical equipment provider’s stock worth $992,000 after acquiring an additional 1,100 shares in the last quarter. Quantbot Technologies LP grew its stake in Integer by 21.5% in the 3rd quarter. Quantbot Technologies LP now owns 6,255 shares of the medical equipment provider’s stock worth $319,000 after acquiring an additional 1,107 shares in the last quarter. Finally, Rhumbline Advisers grew its stake in Integer by 2.0% in the 3rd quarter. Rhumbline Advisers now owns 61,908 shares of the medical equipment provider’s stock worth $3,167,000 after acquiring an additional 1,235 shares in the last quarter. Institutional investors own 95.11% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “” was published by Daily Political and is owned by of Daily Political. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.dailypolitical.com/2018/01/23/1718027.html.
Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.